The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

Study of Breast Cancer Prevention by Letrozole in High Risk Women

NCT00579826 ·Status: COMPLETED ·Phase: PHASE2

RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer

NCT01208441 ·Status: TERMINATED ·Phase: PHASE1

Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women

NCT00237133 ·Status: COMPLETED ·Phase: PHASE4

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

NCT00291759 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer

NCT00330317 ·Status: COMPLETED ·Phase: PHASE3

Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer

NCT01612871 ·Status: COMPLETED ·Phase: PHASE4

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

NCT00382070 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

NCT00248170 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

NCT00256698 ·Status: COMPLETED ·Phase: PHASE3

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

NCT00077025 ·Status: COMPLETED ·Phase: PHASE2

Protocol for Women at Increased Risk of Developing Breast Cancer

NCT00291135 ·Status: COMPLETED ·Phase: PHASE2

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

NCT00544986 ·Status: COMPLETED ·Phase: PHASE4

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

NCT02995772 ·Status: COMPLETED ·Phase: PHASE3

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

NCT00003771 ·Status: COMPLETED ·Phase: PHASE3

Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy

NCT00681928 ·Status: COMPLETED

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer

NCT01080170 ·Status: COMPLETED

Trial of Perioperative Endocrine Therapy - Individualising Care

NCT02338310 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

NCT03264651 ·Status: COMPLETED ·Phase: PHASE1

PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE

NCT00499681 ·Status: TERMINATED ·Phase: PHASE2

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

NCT01814865 ·Status: WITHDRAWN ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

NCT04961996 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer

NCT01298362 ·Status: COMPLETED

Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women

NCT02914158 ·Status: RECRUITING ·Phase: PHASE3